Myopic View of Xenotransplantation
By Franklin G. Miller,
Hastings Bioethics Forum
| 09. 25. 2023
The news media significantly influence public perceptions of medical innovation. How cutting- edge medical innovation is presented—what receives attention and what does not receive attention—is ethically relevant. A report last week in the New York Times of a pig heart transplant performed at the University of Maryland Medical Center exemplifies a common myopic view of xenotransplantation research. The article describes the case of a 58-year-old Navy veteran with end-stage heart disease, too sick to qualify for a human organ transplant, who received instead a genetically modified pig heart—the second patient to undergo this experimental surgical intervention. The patient appears as a heroic volunteer, helping to advance science in the hope of a long shot at extended survival.
The innovative nature of xenotransplantation gets prominent attention. In a breathless tone, the article’s author writes, “In recent years, the science of xenotransplantation has taken huge strides with gene editing and cloning technologies designed to make animal organs less likely to be rejected by the human immune system.” The pig donor, supplied by the for-profit company Revivicor, had 10 genetic modifications. The patient...
Related Articles
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
By Aaron Ginn, The Washington Post | 09.12.2025
Earlier this year, I had dinner in D.C. with Jensen Huang, the president and chief executive of Nvidia. At one point, he said something that struck me: “Why is everyone here so negative?”
He wasn’t referring to the economy...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...